Literature DB >> 26478858

Changing plasmid types responsible for extended spectrum cephalosporin resistance in Escherichia coli O157:H7 in the United States, 1996-2009.

J P Folster1, G Pecic1, S Stroika2, R Rickert2, J Whichard2.   

Abstract

Escherichia coli O157 is a major cause of foodborne illness. Plasmids are genetic elements that mobilize antimicrobial resistance determinants including blaCMY β-lactamases that confer resistance to extended-spectrum cephalosporins (ESC). ESCs are important for treating a variety of infections. IncA/C plasmids are found among diverse sources, including cattle, the principal source of E. coli O157 infections in humans. IncI1 plasmids are common among E. coli and Salmonella from poultry and other avian sources. To broaden our understanding of reservoirs of blaCMY, we determined the types of plasmids carrying blaCMY among E. coli O157. From 1996 to 2009, 3742 E. coli O157 isolates were tested. Eleven (0.29%) were ceftriaxone resistant and had a blaCMY-2-containing plasmid. All four isolates submitted before 2001 and a single 2001 isolate had blaCMY encoded on IncA/C plasmids, while all five isolates submitted after 2001 and a single 2001 isolate had blaCMY carried on IncI1 plasmids. The IncI1 plasmids were ST2, ST20, and ST23. We conclude that cephalosporin resistance among E. coli O157:H7 is due to plasmid-encoded blaCMY genes and that plasmid types appear to have shifted from IncA/C to IncI1. This shift suggests either a change in plasmid type among animal reservoirs or that the organism has expanded into avian reservoirs. More analysis of human, retail meat, and food animal isolates is necessary to broaden our understanding of the antimicrobial resistance determinants of ESC resistance among E. coli O157.

Entities:  

Keywords:  Antimicrobial resistance; Escherichia coli O157:H7; cephalosporin resistance; resistance plasmid

Year:  2014        PMID: 26478858      PMCID: PMC4608858     

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  26 in total

1.  Risk factors for sporadic cases of Escherichia coli O157 infection: the importance of contact with animal excreta.

Authors:  M E Locking; S J O'Brien; W J Reilly; E M Wright; D M Campbell; J E Coia; L M Browning; C N Ramsay
Journal:  Epidemiol Infect       Date:  2001-10       Impact factor: 2.451

2.  -11 Mutation in the ampC promoter increasing resistance to beta-lactams in a clinical Escherichia coli strain.

Authors:  S Corvec; N Caroff; E Espaze; J Marraillac; A Reynaud
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

3.  Survey of Escherichia coli O157 in captive frogs.

Authors:  Ludovico Dipineto; Antonio Gargiulo; Tamara P Russo; Luigi M De Luca Bossa; Luca Borrelli; Dario d'Ovidio; Mariangela Sensale; Lucia F Menna; Alessandro Fioretti
Journal:  J Wildl Dis       Date:  2010-07       Impact factor: 1.535

4.  Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.

Authors:  P L Winokur; D L Vonstein; L J Hoffman; E K Uhlenhopp; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

Review 6.  Escherichia coli O157:H7: animal reservoir and sources of human infection.

Authors:  Witold A Ferens; Carolyn J Hovde
Journal:  Foodborne Pathog Dis       Date:  2010-11-30       Impact factor: 3.171

7.  Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.

Authors:  K Ikeda; O Ida; K Kimoto; T Takatorige; N Nakanishi; K Tatara
Journal:  Clin Nephrol       Date:  1999-12       Impact factor: 0.975

8.  Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada.

Authors:  Laura F Mataseje; Patricia J Baudry; Goerge G Zhanel; Douglas W Morck; Ron R Read; Marie Louie; Michael R Mulvey
Journal:  Diagn Microbiol Infect Dis       Date:  2010-08       Impact factor: 2.803

9.  Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin.

Authors:  Aurora García-Fernández; Giuseppina Chiaretto; Alessia Bertini; Laura Villa; Daniela Fortini; Antonia Ricci; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2008-03-26       Impact factor: 5.790

10.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.